EPIS B — Episurf Medical AB Income Statement
0.000.00%
- SEK166.62m
- SEK136.72m
- SEK10.60m
Annual income statement for Episurf Medical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.4 | 7 | 6.9 | 6.9 | 10.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 74.3 | 70.4 | 76.3 | 83.9 | 107 |
Operating Profit | -68.9 | -63.4 | -69.4 | -77 | -96.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -69.8 | -63.9 | -69.2 | -77.2 | -94.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -69.8 | -63.9 | -69.2 | -77.3 | -94.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -69.8 | -63.9 | -69.2 | -77.3 | -94.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -69.8 | -63.9 | -69.3 | -77.3 | -94.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.8 | -0.304 | -0.236 | -0.224 | -0.274 |
Dividends per Share |